US OptionsDetailed Quotes
SAVA240726P11500
- 0.18
- +0.05+38.46%
15min DelayClose Jul 26 15:50 ET
0.19High0.02Low
0.19Open0.13Pre Close29 Volume127 Open Interest11.50Strike Price531.00Turnover3172.56%IV24.13%PremiumJul 26, 2024Expiry Date0.00Intrinsic Value100Multiplier0DDays to Expiry0.18Extrinsic Value100Contract SizeAmericanOptions Type-0.1022Delta0.0531Gamma82.89Leverage Ratio-16.1377Theta0.0000Rho-8.47Eff Leverage0.0002Vega
Cassava Sciences Stock Discussion
Sign in to post a comment
$Cassava Sciences(SAVA.US$ Really Great News For Patients using Simufilam. Clinical trial sites are very excited about Simufilam. Key quotes from two phase 3 trial sites. Thanks Matt For updates:
6
1
$Cassava Sciences(SAVA.US$ This is Bullish News and shorts are just cheating / manipulating stock price . They will not stop people improving with Simufilam treating Alzheimer’s . Thanks Matt for Update
5
$Cassava Sciences(SAVA.US$ please rise
$Cassava Sciences(SAVA.US$ hop in lets fly 🚆 🚀 🚀
$Cassava Sciences(SAVA.US$ fly fly 🚀
No comment yet
70107211 : Jay, thank you so much for tirelessly provide the true information /news to us all the time!